LPA rs10458370: What Your Genotype Means
The rs10458370 variant is a genetic change located within the LPA gene, which provides instructions for making a protein called apolipoprotein(a). This variant is statistically associated with elevated levels of lipoprotein(a) in the blood and an increased risk for certain cardiovascular conditions, such as coronary artery disease.
What each genotype means
Baseline risk profile
This genotype represents the most common form of this variant in many populations. Research indicates that individuals with this genotype typically do not carry the specific genetic association linked to elevated lipoprotein(a) levels and increased cardiovascular risk at this locus.
This is the most frequent genotype in European populations, where the minor allele is relatively uncommon.
Elevated risk marker
Carrying one copy of the T allele is associated with higher circulating levels of lipoprotein(a) compared to those without it. This elevation is statistically linked to an increased risk for coronary artery disease and aortic stenosis, though individual health outcomes depend on many factors beyond this single variant.
This genotype is found in roughly 10-15% of individuals of European ancestry, but is significantly rarer in East Asian and African populations.
Increased risk marker
Individuals with two copies of the T allele are statistically more likely to have higher lipoprotein(a) concentrations than those with one or no copies. This genotype is associated with a higher predisposition for coronary artery disease and aortic stenosis, and you should discuss your overall cardiovascular risk profile with your healthcare provider.
This genotype is relatively rare, occurring in less than 1% of individuals of European ancestry and is very uncommon in other global populations.
Understanding the rs10458370 Variant
The rs10458370 variant is a single-nucleotide polymorphism (SNP) located within the LPA gene on chromosome 6. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is categorized as an intronic variant, meaning it sits within a non-coding region of the gene. While it does not directly change the protein sequence, it is located in a region that influences how the LPA gene is regulated or expressed. Researchers track these variants to understand how subtle differences in our genetic code can influence biological traits, such as the concentration of specific proteins circulating in our bloodstream. Because it is inherited, this variant is passed from parents to children, and its presence can be identified through genomic testing.
The Role of the LPA Gene
The LPA gene is responsible for producing apolipoprotein(a), a protein that attaches to a cholesterol-rich particle known as low-density lipoprotein (LDL) to form lipoprotein(a), or Lp(a). Lipoprotein(a) is a complex particle that circulates in the blood. While the exact physiological function of Lp(a) is still being studied, high levels of this particle are widely recognized in medical research as an independent risk factor for cardiovascular issues. The LPA gene is highly polymorphic, meaning it contains many variations that can affect both the size and the amount of Lp(a) produced by the body. Variations in this gene are the primary genetic determinants of an individual's baseline Lp(a) levels, which are largely established at birth and remain relatively stable throughout a person's life.
Research and Cardiovascular Associations
Extensive research, including large-scale genome-wide association studies (GWAS), has consistently linked variants in the LPA gene region to cardiovascular health. Specifically, rs10458370 has been identified as a marker associated with higher circulating levels of Lp(a). Epidemiological studies suggest that individuals with higher Lp(a) levels face a statistically increased risk for conditions such as coronary artery disease and aortic stenosis. It is important to note that while the association between this genetic variant and Lp(a) levels is strong, the evidence regarding its individual contribution to clinical disease outcomes is considered complex. Many factors, including lifestyle, diet, and other genetic markers, contribute to overall heart health. Therefore, this variant is viewed as one piece of a much larger puzzle rather than a definitive predictor of disease.
Population Frequency and Distribution
The frequency of the rs10458370 variant varies significantly across different ancestral groups. In European populations, the minor allele frequency is typically observed between 0.05 and 0.08. Conversely, this variant is considered rare in populations of East Asian and African ancestry. These differences highlight the importance of considering genetic background when interpreting genomic data. Because the variant is not distributed uniformly across the globe, its potential impact on health traits may differ depending on an individual's heritage. Understanding these population-specific frequencies helps researchers refine their studies and ensures that genetic insights are interpreted within the correct context of human diversity.
Interpreting Your Genetic Information
If you have information about your rs10458370 genotype, it is helpful to view it as a statistical observation rather than a medical diagnosis. Genetic variants are common, and having a specific genotype does not guarantee that you will develop any particular health condition. You cannot change your genetic sequence, but you can manage your cardiovascular health through regular check-ups, healthy lifestyle choices, and discussions with your healthcare provider. If you are concerned about your cardiovascular risk or your Lp(a) levels, consult a physician or a cardiologist. They can order appropriate blood tests to measure your actual Lp(a) levels and assess your overall heart health. Never make changes to medications or health routines based solely on genetic reports without first consulting a qualified medical professional.
How common is this variant?
The minor allele frequency for rs10458370 is approximately 0.05 to 0.08 in European populations, while it is rare in East Asian and African ancestries.
Frequently asked questions
Is rs10458370 a cause of heart disease?
The variant is statistically associated with higher levels of lipoprotein(a), which is a known risk factor for heart disease. However, it is not a direct cause, and many people with this variant do not develop heart disease.
Can I change my genotype for rs10458370?
No, your genetic sequence is inherited from your parents and remains the same throughout your life. You cannot change your genotype, but you can manage your cardiovascular health through lifestyle and medical care.
Should I get my Lp(a) levels tested?
If you are concerned about your cardiovascular risk, you should discuss testing with your doctor. A blood test is the only way to determine your actual circulating lipoprotein(a) levels.
Does this variant affect how I respond to statins?
Some research suggests that LPA variants may be associated with cardiovascular risk even in patients taking statins. You should discuss your specific cardiovascular risk profile and medication management with your clinician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10458370?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LPA
This variant in the LPA gene elevates serum lipoprotein(a) levels, significantly increasing the risk of coronary atherosclerosis and aortic stenosis.
Variant in the LPA gene locus associated with circulating lipoprotein(a) levels and cardiovascular healthspan.
Intronic splice-affecting variant in LPA leading to elevated plasma lipoprotein(a) concentrations and increased risk of aortic valve stenosis and coronary disease.
A splice-altering variant in LPA that lowers circulating lipoprotein(a) levels and is significantly associated with extended parental attained age and healthspan.
This variant is strongly associated with significantly elevated levels of Lipoprotein(a), a major independent risk factor for heart disease.
An LPA-locus variant identified as an independent genetic determinant of human healthspan and disease-free survival through modulated cardiovascular risk.